Send Email Send Email
Kyprolis 60 mg Injection Kyprolis 60 mg Injection Kyprolis 60 mg Injection Kyprolis 60 mg Injection Kyprolis 60 mg Injection

Kyprolis 60 mg Injection

37500.0 INR
Get a Price/Quote

Product Details:

  • Pacakaging (Quantity Per Box) 1 vial per box
  • Brand Name Kyprolis
  • Salt Composition Carfilzomib 60 mg
  • Indication For the treatment of relapsed or refractory multiple myeloma
  • Dosage Form Lyophilized powder for solution for infusion
  • Origin of Medicine United States
  • Life Span Refer to expiry on the pack
  • Click to view more
Request To Call Back Send Inquiry
X

Kyprolis 60 mg Injection Price And Quantity

  • 6 Piece
  • 37500.0 INR
  • To be administered by qualified healthcare professionals only
  • L01XX45
  • Lyophilized white to off-white powder
  • Rx only (requires prescription)
  • May include anemia, thrombocytopenia, neutropenia, and cardiac events
  • Antineoplastic agents
  • Hypersensitivity to Carfilzomib or excipients
  • As per manufacturer's label
  • Intravenous
  • Amgen Biotech
  • For hospital use only; keep out of reach of children
  • Required before administration, follow SPC instructions
  • Supplied with each pack
  • Dispose of according to local requirements for cytotoxic agents

Kyprolis 60 mg Injection Product Specifications

  • Follow medical advice and prescription guidelines
  • DOCTOR
  • Adults
  • 6 Pieces
  • For the treatment of relapsed or refractory multiple myeloma
  • United States
  • Prescription Only
  • Refer to expiry on the pack
  • Vial
  • Store below 25C, protect from light
  • Carfilzomib
  • Lyophilized powder for solution for infusion
  • Anticancer/Proteasome inhibitor
  • As prescribed by the physician
  • Kyprolis
  • Carfilzomib 60 mg
  • Powder
  • 1 vial per box
  • To be administered by qualified healthcare professionals only
  • L01XX45
  • Lyophilized white to off-white powder
  • Rx only (requires prescription)
  • May include anemia, thrombocytopenia, neutropenia, and cardiac events
  • Antineoplastic agents
  • Hypersensitivity to Carfilzomib or excipients
  • As per manufacturer's label
  • Intravenous
  • Amgen Biotech
  • For hospital use only; keep out of reach of children
  • Required before administration, follow SPC instructions
  • Supplied with each pack
  • Dispose of according to local requirements for cytotoxic agents

Kyprolis 60 mg Injection Trade Information

  • 1 Week

Product Description

Kyprolis 60 mg injection is a potent medication classified as a protease inhibitor, specifically designed for the treatment of multiple myeloma, a malignancy that affects the blood's plasma cells. By inhibiting the activity of proteases, Kyprolis disrupts critical cellular processes, effectively slowing or halting the proliferation of cancer cells. This innovative therapy is often utilized in combination with other treatments to enhance efficacy and improve patient outcomes. Patients receiving Kyprolis may experience side effects, including fatigue, diarrhea, and potential cardiovascular issues, necessitating careful monitoring by healthcare professionals. It is crucial for patients to discuss their complete medical history and any other medications they are taking with their doctor prior to starting this treatment. As with any cancer therapy, the benefits and risks should be weighed thoughtfully to ensure the best possible approach to managing multiple myeloma. If you or a loved one is considering Kyprolis, consult with a healthcare provider to understand its role in your treatment plan.

Highly Targeted Anticancer Therapy

Kyprolis works by selectively inhibiting proteasomes, essential protein complexes in cancer cells, which helps halt the growth of multiple myeloma. Its targeted mechanism makes it a significant option for patients experiencing relapse or resistance to other treatments. This therapy is strictly administered under professional supervision for safety and optimum efficacy.


Strict Professional Administration

Administration of Kyprolis is limited to infusion by healthcare professionals in a hospital setting. Reconstitution is required prior to infusion, following the specific protocol outlined in the SPC. Handling precautions and disposal procedures are rigorously maintained due to the cytotoxic nature of the medication.

FAQ's of Kyprolis 60 mg Injection:


Q: How is Kyprolis 60 mg Injection administered?

A: Kyprolis is administered intravenously by qualified healthcare professionals, following reconstitution as per the SPC instructions. It should only be given in a hospital setting.

Q: What is Kyprolis 60 mg Injection used for?

A: Kyprolis is indicated for the treatment of adults with relapsed or refractory multiple myeloma. It helps target and inhibit cancer cell growth, improving outcomes for suitable patients.

Q: When should Kyprolis not be used?

A: Kyprolis must not be used in patients who have hypersensitivity to carfilzomib or any of its excipients. It is also not intended for use in children and should only be administered as prescribed by a physician.

Q: Where should Kyprolis vials be stored before use?

A: Store the vials below 25C and protect them from light. Always refer to the manufacturer's label for the precise shelf life and storage guidelines.

Q: What is the process for preparing Kyprolis for administration?

A: Kyprolis requires reconstitution before intravenous infusion. The preparation must be performed by professionals, strictly adhering to the SPC instructions to ensure correct dosing and patient safety.

Q: How should unused Kyprolis or waste material be disposed of?

A: Unused product or waste should be disposed of in accordance with local regulations for cytotoxic agents. This ensures environmental safety and compliance with healthcare standards.

Q: What are the potential benefits of using Kyprolis for multiple myeloma?

A: Kyprolis offers an advanced therapeutic option for patients with relapsed or refractory multiple myeloma, potentially improving response rates and prolonging progression-free survival when previous treatments have failed.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Injection' category

Luprodex Depot 22.5 mg Injection
Send Inquiry
Epithra 10 mg Injection
Send Inquiry
Bufatas IV Injection
Send Inquiry
Cytalon 100 mg Injection
Send Inquiry
SEND INQUIRY CALL ME FREE


Contact Details
Address

    GST : 24ABNCS9569B1ZX

  • D-620, Swati Clover, Shilaj Cross Road, S. P. Ring Road, Shilaj,Ahmedabad - 380059, Gujarat, India
  • Phone : 08071930881
Key Personnel
  • Mr Siddharth Patel (MANAGING DIRECTOR)
  • Mobile : 08071930881
Quick Links
Our Products
View All
  • trusted seller
  • Send Inquiry Send Inquiry
    Send SMS Send SMS
       
    Call Me Call Me Free
    Back to top
    Tradeindia
    SIDMEX INOVIA PRIVATE LIMITED All Rights Reserved.(Terms of Use)
    Developed and Managed by Infocom Network Private Limited.
    Change Language